Dermapharm Holding SE

Dermapharm Holding SE

World Rank (Jan-05-2024)
4,956
Market Cap (Jan-05-2024)
2.498 Billion USD
World Rank (Jul-30-2023)
4,812
Market Cap (Jul-30-2023)
2.594 Billion USD
World Rank (Jan-07-2022)
3,390
Market Cap (Jan-07-2022)
4.799 Billion USD
World Rank (Jan-01-2021)
3,673
Market Cap (Jan-01-2021)
3.758 Billion USD
Company Rank in Country in 2023
Rank in Germany in July-2023 is 103
Headquarters Country
Germany
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
1,129 Million USD
Annual Operating Income in USD
267 Million USD
Annual Net Income in USD
148 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,557 Million USD
Total Liabilities in USD
970 Million USD
Total Equity in USD
587 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
DERMAPHARM HOLDING SE
Yahoo
Yahoo @ Frankfurt
Company Profile

Dermapharm Holding SE is a Pharmaceutical company. It has around 950 marketing authorizations for more than 250 active pharmaceutical ingredients. The company annual revenue is 700.9 million EUR as on 2019. The headquarters is in Germany.

Annual Results Summary

DERMAPHARM HOLDING SE - Yearly Revenue and Net Income - in Million EUR:

Year - EndingRevenueOperating IncomeNet Income
Dec-20221,024242134
Dec-2021942287209
Dec-2020793145 85
Dec-2019700 11977
Dec-201857210875
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,412 Million EUR.

Total Liabilities as on Dec-2022 was 880 Million EUR.

Total Equity as on Dec-2022 was 532 Million EUR.

Founded Year
1991
ISIN Code
DE000A2GS5D8
Stock Exchange
Deutsche Borse
Frankfurt
Company SubCategory
Top Healthcare Companies in Europe

Share